Publications

5532 Results

The role of alpha interferon (rINFa2a) maintenance in patients with limited stage SCLC responding to con-current chemoradiation: A Southwest Oncology Group study.

Authors
K Kelly;PA Bunn Jr;M Hazuka;K Beasley;J Crowley;R Livingston
Journal / Conference
ASCO 12:330(#1099)
Year
1993
Research Committee(s)
Lung
Study Number(s)
SWOG-8812

A phase II trial of continuous infusion recombinant interleukin-2 (rIL-2) in patients with advanced renal cell carcinoma. A Southwest Oncology Group study.

Authors
RP Whitehead;MK Wolf;DL Solanki;P Benedetto;RC Flanigan;ED Crawford
Journal / Conference
ASCO 12:253(#799)
Year
1993
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8824

Fluorouracil (5-FU) schedules and modulation in advanced colorectal cancer (CRC): A Southwest Oncology Group screening trial.

Authors
CG Leichman;TR Fleming;FM Muggia;B Ardalan;J Doroshow;C Tangen;J Macdonald
Journal / Conference
ASCO 12:198(#583)
Year
1993
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8905

The addition of tamoxifen (T) to dacarbazine (D) and cisplatin (C) in a Southwest Oncology Group phase II trial (8921) in metastatic malignant melanoma (MMM) stage IV.

Authors
L Flaherty;PY Liu;D Daniels;V Sondak
Journal / Conference
ASCO 12:394(#1349)
Year
1993
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8921

Evaluation of cisplatin + 5 fluorouracil infusion for advanced/metastatic transitional cell carcinoma of the bladder. (AMTCCB). A Southwest Oncology Group study.

Authors
JA Kish;M Wolf;S Taylor;A Einstein;ED Crawford
Journal / Conference
ASCO 34:203(#1214)
Year
1993
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8956

Modulation of intratumoral (IT) 5FU pharmacokinetics (PK) by leucovorin (LV) and methotrexate (M) documented by 19F-magnetic resonance spectroscopy (MRS) initial results of Southwest Oncology Group studies 9006 and 9118.

Authors
CA Presant;M Wolf;V Waluch;B Ardalan;R Brechner;C Wiseman;DW Blayney;P Kennedy
Journal / Conference
ASCO 12:201(#596)
Year
1993
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9006, SWOG-9118

A phase II trial of taxol and granulocyte colony stimulating factor (G-CSF) in patients with adenocarcinoma of the pancreas.

Authors
T Brown;C Tangen;T Fleming;J Macdonald
Journal / Conference
ASCO 12:200(#592)
Year
1993
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9135

Effects of prior hormone therapy on response and survival in Southwest OncologyGroup phase II chemotherapy trials.

Authors
M Hussain;M Wolf;E Marshall;ED Crawford;M Eisenberger
Journal / Conference
ASCO 12:243(#760)
Year
1993

Assessment of response to new agents for primary CNS malignancies (CNS).

Authors
SA Taylor;C Upchurch;W Goodwin;T Brown;G Selby;FS Vogel;H Eyre
Journal / Conference
ASCO 12:176(#502)
Year
1993

Phase II trial of mitotane (o, p'DDD) and cisplatin in patients with adrenal carcinoma: A Southwest Oncology Group study.

Authors
RM Bukowski;M Wolf;HS Levine;ED Crawford;RL Stephens;E Gaynor;WG Harker
Journal / Conference
JCO 11:161-165
Year
1993
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8325